ProPhase Labs Inc (NAS:PRPH)
$ 4.81 -0.18 (-3.61%) Market Cap: 91.77 Mil Enterprise Value: 117.12 Mil PE Ratio: 0 PB Ratio: 1.93 GF Score: 55/100

Prophase Labs Inc at Q4 Investor Summit Transcript

Nov 14, 2022 / 08:00PM GMT
Release Date Price: $11.96 (-0.75%)
Ted Karkus
ProPhase Labs, Inc. - Chairman & CEO

All right. Greetings, all. Thank you for joining me today and thank you online. I have no idea how many people are watching us online. I am Ted Karkus, Chairman and CEO of ProPhase Labs. This actually -- what you're looking at right now is actually our headquarters in Garden City, New York.

This presentation, by the way, is on our website. We also have a roughly 35-slide presentation just on our biotech division. I'm going to touch on that. I only got about 20 minutes, and we are doing so many things at our company. It's very hard to even give an overview of what we're doing in 20 minutes, but I'm going to try.

Of course, forward-looking statement, I'm going to presume that everybody has read the forward-looking statement. Everything I say comes from the heart. Everything I say is true as of today.

I can tell you, historically, whatever I say, most of the time it comes true. I have long-term shareholders who are very supportive of me. And if anything, over time, we tend to outperform, not underperform. I'm a big believer in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot